alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### Ground water in the coastal dune area near Florence, Oregon

By: E. R. Hampton

                            https://doi.org/10.3133/wsp1539K

#### Links

- More information:  **National Geologic Map Database Index Page**                            (html)
-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plate:  **Plate 1**                            (pdf)
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
§ 640.51 Eligibility of donors. ( a ) Whole blood donors must meet the criteria for eligibility prescribed in §§ 630.10 and 630.15 of this chapter.
( b ) Collection establishments must determine the eligibility of plasmapheresis donors in accordance with §§ 630.10 and 630.15 of this chapter.
[80 FR 29905, May 22, 2015]
IN THE SUPREME COURT OF THE STATE OF DELAWARE 

DELAWARE DEPT. OF § 

NATURAL RESOURCES AND § 

ENVIRONMENTAL CONTROL, § 

and DAVID S. SMALL, § 

§ No. 552, 2015 

 Defendants-Below, § 

 Appellants, § 

§ Court Below: Superior Court 

v. § of the State of Delaware 

 § 

W. WAYNE BAKER, CHRISTIAN § C.A. No. S13C-08-026 

HUDSON, JAMIN HUDSON, § 

JOHN F. CLARK, HOLLYVILLE § 

FARMS, LLC, and ROUTE 24 CJ, § 

LLC, § 

 § 

 Plaintiffs-Below, § 

 Appellees. § 

Submitted: April 13, 2016 

Decided: April 15, 2016 

Before HOLLAND, VAUGHN, and SEITZ, Justices. 

ORDER

 This 15th day of April, 2016, after careful consideration of the parties’ briefs 

and the record on appeal, we find it evident that the judgment of the Superior Court 

should be affirmed on the basis of and for the reasons assigned by the Superior 

Court in its October 7, 2015 Memorandum Decision. 
2 

 NOW, THEREFORE, IT IS ORDERED that the judgment of the Superior 

Court is AFFIRMED. 

 BY THE COURT: 

 /s/ Collins J. Seitz, Jr.

 Justice
<PAGE>
                                                                   EXHIBIT 10.15

                          AMENDMENT OF PROMISSORY NOTE



     This Amendment of Promissory Note is made as of August 1, 1997, between
KeraVision, Inc. (the "COMPANY") and Mark Fisher-Colbrie (the "PURCHASER").

     The Promissory Note ("NOTE") executed by the Purchaser on November 7, 1993,
under which the Purchaser promised to pay to the Company $28,125.00, plus
interest, on or before October 21, 1997, is hereby amended as follows:

     (1) On October 24, 1996, the Company forgave $5,000 of the principal amount
of this Note.  The Company and the Purchaser hereby agree that the interest due
with respect to the Note as of the date hereof is $5,303.65, which amount is
hereby added to the original principal amount of the Note less the $5,000
forgiveness of principal by the Company, such that the principal as of the date
hereof is $28,428.65.

     (2) The due date of all principal and interest under the Note is hereby
extended to August 1, 1999.

     (3) The interest rate of the Note changes as of this Amendment Date from
the original  4.86% per annum, compounded semi-annually, to 5.79% per annum,
compounded semi-annually.



KERAVISION, INC.                 MARK FISHER-COLBRIE


/s/ Thomas M. Loarie             /s/ Mark Fischer-Colbrie
-----------------------          ----------------------------
Signature                        Signature


By: Thomas M. Loarie
    ----------------
     Print Name

Title:   President & CEO
         ---------------
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
Pursuant to 18 U.S.C. Section 1350, as adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned, John P. Wilmers, Chief Executive Officer of Ballantyne of Omaha, Inc. (the "Company"), has executed this certification in connection with
the filing with the Securities and Exchange Commission of the Company's Annual Report on Form 10-K for the year ended December 31, 2007 (the "Report").

The
undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to his knowledge that:



IN
WITNESS WHEREOF, the undersigned has executed this certification as of the 1st day of April 2008.

|/s/JOHN P. WILMERSJohn P. Wilmers
Chief Executive Officer |  | 
|--------------------------------------------------------- |  | 

A signed original of this written statement required by Section 906 has been provided to Ballantyne of Omaha, Inc. and will be retained by
Ballantyne of Omaha, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

---



QuickLinks
#### § 350.3 Definition.

As used in this part:

*Antiperspirant.* A drug product applied topically that reduces the production of perspiration (sweat) at that site.
Exhibit 31.3




CERTIFICATIONS





I, W. Thomas Amick, certify that:





1.     I have reviewed this Amendment No. 1 on Form 10-K/A for the fiscal year ended December 31, 2011 of Discovery Laboratories, Inc.; and





2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.





Date:  April 27, 2012
/s/ W. Thomas AmickW. Thomas AmickChairman of the Boardand Chief Executive Officer
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

MERJEME AVILES, as Guardian of PENELOPI BITSI,

Appellant,

v.

HEIDI BITSI,

Appellee.

No. 4D22-593

[March 23, 2023]

Appeal from the Circuit Court for the Fifteenth Judicial Circuit, Palm 

Beach County; James Nutt, Judge; Case No. 502019CA000463.

Craig A. Boudreau, West Palm Beach, for appellant. 

Marshall J. Osofsky, Law Office of Paul A. Krasker, P.A., for appellee.

PER CURIAM.

Affirmed.

GROSS, CONNER and FORST, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
§ 530.40 Safe levels and availability of analytical methods. ( a ) In accordance with § 530.22, the following safe levels for extralabel use of an approved animal drug or human drug have been established: [Reserved]
( b ) In accordance with § 530.22, the following analytical methods have been accepted by FDA: [Reserved]
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED NOVEMBER 29, 2022

NO. 03-22-00347-CV

Y. A., Appellant

v.

Texas Department of Family and Protective Services, Appellee

APPEAL FROM THE 345TH DISTRICT COURT OF TRAVIS COUNTY

BEFORE CHIEF JUSTICE BYRNE, JUSTICES TRIANA AND SMITH

AFFIRMED -- OPINION BY JUSTICE TRIANA

CONCURRING OPINION BY CHIEF JUSTICE BYRNE

This is an appeal from the order signed by the trial court on May 16, 2022. Having reviewed the 

record and the parties’ arguments, the Court holds that there was no reversible error in the trial 

court’s order. Therefore, the Court affirms the trial court’s order. Because appellant is indigent 

and unable to pay costs, no adjudication of costs is made.
§ 640.101 General requirements. ( a ) *Heat stability test.* Approximately 2 ml. of completely processed material of each lot shall not show any visible sign of gelation after heating in a 12 × 75 mm. stoppered glass tube at 57 °C for 4 hours.
( b ) *pH.* The pH of final container material shall be 6.8 ±0.4 when measured in a solution diluted to 1 percent protein with 0.15 molar sodium chloride.
( c ) *Turbidity.* The product shall be free of turbidity as determined by visual inspection of final containers.
( d ) *Date of manufacture.* The date of manufacture is the date of initiating the last valid measles or poliomyelitis antibody test (§ 640.104(b) (2) and (3)) whichever date is earlier.
( e ) *Labeling.* In addition to complying with all applicable labeling required in this subchapter, labeling shall indicate that: ( 1 ) There is no prescribed potency for viral hepatitis antibodies.
( 2 ) The product is not recommended for intravenous administration.
[38 FR 32089, Nov. 20, 1973; 48 FR 13026, Mar. 29, 1983, as amended at 49 FR 23834, June 8, 1984; 50 FR 4140, Jan. 29, 1985; 51 FR 15611, Apr. 25, 1986; 55 FR 11013, Mar. 26, 1990; 63 FR 16685, Apr. 6, 1998; 64 FR 26287, May 14, 1999]
##### 



Exhibit 31(b) REPUBLIC BANCORP INC.
Certification of the Principal Financial Officer
Pursuant to 15 U.S.C. 78m(a) or 78o(d)
(Section 302 of the Sarbanes-Oxley Act of 2002) I, Thomas F. Menacher, certify that:  1.
    
    I have reviewed this report on Form 10-Q of Republic Bancorp Inc;2.
    
    Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this report;4.
    
    The registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and we have:  a)
    
    designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the
period in which this report is being prepared;b)
    
    evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such
evaluation; andc)
    
    disclosed in this report any change in the registrants
internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth
fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the
registrants internal control over financial reporting; and  5.
    
    The registrants other certifying officer and I have disclosed, based
on our most recent evaluation of internal control over financial
reporting, to the registrants auditors and the audit committee of the
registrants board of directors (or persons performing the equivalent
functions):  a)
    
    all significant deficiencies and material weaknesses in the
design or operation of internal controls over financial reporting
which are reasonably likely to adversely affect the registrants
ability to record, process, summarize and report financial
information; andb)
    
    any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrants
internal control over financial reporting. Date: May 7, 2004
    
    /s/ Thomas F. MenacherThomas F. MenacherExecutive Vice President, Treasurerand Chief Financial Officer
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



     In connection  with the Quarterly  Report of CEC  Entertainment,  Inc. (the
"Company")  on Form 10-Q for the quarter  ended March 28, 2004 as filed with the
Securities  and  Exchange  Commission  on the date  hereof (the  "Report"),  the
undersigned  certifies,  pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:


     (1)  The Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.




                                             /s/ Richard M. Frank
                                             ---------------------------
                                             Richard M. Frank
                                             Chief Executive Officer
                                             May 6, 2004



A signed  original of this  written  statement  required by Section 906 has been
provided to CEC  Entertainment,  Inc. and will be retained by CEC Entertainment,
Inc. and furnished to the Securities  and Exchange  Commission or its staff upon
request.
§ 582.5411 Lysine. ( a ) *Product.* Lysine (L- and DL-forms).
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
§ 74.1328 D&C Red No. 28. ( a ) *Identity.* ( 1 ) The color additive D&C Red No. 28 is principally the disodium salt of 2′,4′,5′,7′-tetrabromo-4,5,6,7-tetrachlorofluorescein (CAS Reg. No. 18472-87-2) formed by alkaline hydrolysis of the parent tetrabromotetrachlorofluorescein.
( 2 ) Color additive mixtures for drug use made with D&C Red No. 28 may contain only those diluents that are suitable and that are listed in part 73 of this chapter as safe for use in color additive mixtures for coloring drugs.
( b ) *Specifications.* D&C Red No. 28 shall conform to the following specifications and shall be free from impurities other than those named to the extent that such impurities may be avoided by current good manufacturing practice: Sum of volatile matter (at 135 °C) and halides and sulfates (calculated as sodium salts), not more than 15 percent. Insoluble matter (alkaline solution), not more than 0.5 percent. Tetrachlorophthalic acid, not more than 1.2 percent. Brominated resorcinol, not more than 0.4 percent. 2,3,4,5-Tetrachloro-6-(3,5-dibromo-2,4-dihydroxybenzoyl)benzoic acid, not more than 0.7 percent. 2′,4′,5′,7′-Tetrabromo-4,5,6,7-tetrachlorofluorescein, ethyl ester, not more than 2 percent. Lower halogenated subsidiary colors, not more than 4 percent. Lead (as Pb), not more than 20 parts per million. Arsenic (as As), not more than 3 parts per million. Mercury (as Hg), not more than 1 part per million. Total color, not less than 85 percent.
( c ) *Uses and restrictions.* D&C Red No. 28 may be safely used for coloring drugs generally in amounts consistent with current good manufacturing practice.
( d ) *Labeling.* The label of the color additive and any mixtures prepared therefrom intended solely or in part for coloring purposes shall conform to the requirements of § 70.25 of this chapter.
( e ) *Certification.* All batches of D&C Red No. 28 shall be certified in accordance with regulations in part 80 of this chapter.
[47 FR 42568, Sept. 28, 1982]
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in Local Rule

47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 97-60072

Summary Calendar

 

HOANG LY,

Petitioner,

versus

IMMIGRATION AND NATURALIZATION SERVICE,

Respondent.

- - - - - - - - - -

Petition for Review of an Order of the

Board of Immigration Appeals

BIA No. A 23-140-430

- - - - - - - - - -

June 10, 1997

Before SMITH, DUHE’ and BARKSDALE, Circuit Judges.

PER CURIAM:*

Hoang Thanh Ly seeks leave to proceed in forma pauperis

(IFP) in his petition for review of the order of the Board of

Immigration Appeals (BIA) affirming the order of the Immigration

Judge (IJ) ordering Ly deported. Ly’s IFP motion is denied.

This court must examine the basis of its jurisdiction on its

own motion if necessary. Mosley v. Cozby, 813 F.2d 659, 660 (5th

Cir. 1987). We lack jurisdiction to review a BIA decision
No. 97-60072

- 2 -

ordering deportation for conviction of an aggravated felony.

8 U.S.C. § 1252(a)(2)(C); see 8 U.S.C. § 1251(a)(2)(A)(iii). 

Ly’s burglary conviction is an aggravated felony under the

immigration laws. 8 U.S.C. § 1101(a)(43)(G). Because we lack

jurisdiction to review the BIA’s order, Ly’s petition is

dismissed.

IFP DENIED; PETITION DISMISSED.
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.170 Grape skin extract (enocianina). ( a ) *Identity.* ( 1 ) The color additive grape skin extract (enocianina) is a purplish-red liquid prepared by the aqueous extraction (steeping) of the fresh deseeded marc remaining after grapes have been pressed to produce grape juice or wine. It contains the common components of grape juice; namely, anthocyanins, tartaric acid, tannins, sugars, minerals, etc., but not in the same proportions as found in grape juice. During the steeping process, sulphur dioxide is added and most of the extracted sugars are fermented to alcohol. The extract is concentrated by vacuum evaporation, during which practically all of the alcohol is removed. A small amount of sulphur dioxide may be present.
( 2 ) Color additive mixtures for food use made with grape skin extract (enocianina) may contain only those diluents listed in this subpart as safe and suitable in color additive mixtures for coloring foods.
( b ) *Specifications.* Grape skin extract (enocianina) shall conform to the following specifications: Pesticide residues, not more than permitted in or on grapes by regulations promulgated under section 408 of the Federal Food, Drug, and Cosmetic Act. Lead (as Pb), not more than 10 parts per million. Arsenic (as As), not more than 1 part per million.
( c ) *Uses and restrictions.* Grape skin extract (enocianina) may be safely used for the coloring of still and carbonated drinks and ades, beverage bases, and alcoholic beverages subject to the following restrictions: ( 1 ) It may not be used to color foods for which standards of identity have been promulgated under section 401 of the act unless artificial color is authorized by such standards.
( 2 ) Its use in alcoholic beverages shall be in accordance with the provisions of parts 4 and 5, title 27 CFR.
( d ) *Labeling requirements.* The label of the color additive and any mixtures prepared therefrom intended solely or in part for coloring purposes shall conform to the requirements of § 70.25 of this chapter. The common or usual name of the color additive is “grape skin extract” followed, if desired, by “(enocianina)”.
( e ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches thereof are exempt from the certification requirements of section 721(c) of the act.
# C_2014315EN.01003901.xml

| 15.9.2014 | EN | Official Journal of the European Union | C 315/39 |
| --- | --- | --- | --- |

15.9.2014

EN

Official Journal of the European Union

C 315/39

---

Reference for a preliminary ruling from Upper Tribunal (Immigration and Asylum Chamber) London (United Kingdom) made on 24 June 2014 — Secretary of State for the Home Department v CS

(Case C-304/14)

2014/C 315/62

Language of the case: English

Referring court

Referring court

Upper Tribunal (Immigration and Asylum Chamber) London

Parties to the main proceedings

Parties to the main proceedings

Applicant: Secretary of State for the Home Department

Applicant:

Defendant: CS

Defendant:

Questions referred

Questions referred

| 1. | Does European Union law, and in particular Article 20 TFEU, preclude a Member State from expelling from its territory to a non-Union country, a non-Union national who is the parent and primary carer of a child who is a citizen of that Member State (and, consequently, a citizen of the Union), where to do so would deprive the Union citizen child of the genuine enjoyment of the substance of his or her rights as a European Union citizen? |
| --- | --- |

1.

Does European Union law, and in particular Article 20 TFEU, preclude a Member State from expelling from its territory to a non-Union country, a non-Union national who is the parent and primary carer of a child who is a citizen of that Member State (and, consequently, a citizen of the Union), where to do so would deprive the Union citizen child of the genuine enjoyment of the substance of his or her rights as a European Union citizen?

| 2. | If the answer to Question (1) is ‘No’, in what circumstances would such an expulsion be permitted under European Union Law? |
| --- | --- |

2.

If the answer to Question (1) is ‘No’, in what circumstances would such an expulsion be permitted under European Union Law?

| 3. | If the answer to Question (1) is ‘No’, to what extent, if any, do Articles 27 and 28 of Directive 2004/38/EC (1)(the ‘Citizens Directive’) inform the answer to Question (2)? |
| --- | --- |

3.

If the answer to Question (1) is ‘No’, to what extent, if any, do Articles 27 and 28 of Directive 2004/38/EC (1)(the ‘Citizens Directive’) inform the answer to Question (2)?

1

---

(1)  Directive 2004/38/EC of the European Parliament and of the Council of 29 April 2004 on the right of citizens of the Union and their family members to move and reside freely within the territory of the Member States. OJ L 158, p. 77

1

---